Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women.
暂无分享,去创建一个
E Tafeit | K. Crailsheim | R. Möller | K Crailsheim | E. Tafeit | K Sudi | R Horejsi | R Möller | S Rackl | A Giuliani | U Freytag | R. Horejsi | A. Giuliani | K. Sudi | S. Rackl | U. Freytag
[1] S. Kirchengast,et al. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. , 2001, Human reproduction.
[2] S. Franks,et al. Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.
[3] T R Pieber,et al. Differences of subcutaneous adipose tissue topography in type-2 diabetic (NIDDM) women and healthy controls. , 2000, American journal of physical anthropology.
[4] David Stewart,et al. The Application and Misapplication of Factor Analysis in Marketing Research , 1981 .
[5] H. Kaiser,et al. Little Jiffy, Mark Iv , 1974 .
[6] Gilbert Reibnegger,et al. The determination of three subcutaneous adipose tissue compartments in non-insulin-dependent diabetes mellitus women with artificial neural networks and factor analysis , 1999, Artif. Intell. Medicine.
[7] I. Vauhkonen,et al. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome , 2000 .
[8] R. Pasquali,et al. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women * , 1993, Clinical endocrinology.
[9] E. Renard,et al. Influences of weight, body fat patterning and nutrition on the management of PCOS. , 1997, Human reproduction.
[10] J. López-Fernández,et al. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. , 1999, Fertility and sterility.
[11] A. Lanzone,et al. Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome. , 1999, Human reproduction.
[12] J. Schenker,et al. Endocrinology: Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups , 1995 .
[13] C. Christiansen,et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. , 1991, Metabolism: clinical and experimental.
[14] A. Dunaif,et al. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.
[15] G. Reibnegger,et al. Quantifying the 'appleness' or 'pearness' of the human body by subcutaneous adipose tissue distribution , 2000, Annals of human biology.
[16] Gilbert Reibnegger,et al. Estimating percentage total body fat and determining subcutaneous adipose tissue distribution with a new noninvasive optical device LIPOMETER , 2000, American journal of human biology : the official journal of the Human Biology Council.
[17] J. Wadsworth,et al. POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.
[18] E. Renard,et al. Body Composition and Regional Fat Distribution in Polycystic Ovarian Syndrome Relationship to Hormonal and Metabolic Profiles , 1993, Annals of the New York Academy of Sciences.
[19] P. Björntorp,et al. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. , 1985, The Journal of clinical investigation.
[20] R. Mueller,et al. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. , 1987, The Journal of clinical endocrinology and metabolism.
[21] H. Kaiser. A second generation little jiffy , 1970 .
[22] Gilbert Reibnegger,et al. Measurement of subcutaneous adipose tissue topography (SAT‐Top) by means of a new optical device, LIPOMETER, and the evaluation of standard factor coefficients in healthy subjects , 2000, American journal of human biology : the official journal of the Human Biology Council.